Rekvina Laboratories Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:50

Company Profile

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

ExchangeBSE

Market Capitalization333.59 mln

Float0.15 mln

Piotroski F-Score

5 / 9

Neutral

Relative Strength

93 / 100

Top performer

Pre-Tax Margin

-18%

Loss-making

Altman Z-Score

10.84

Exceptional

ROA

-78.66

Deeply negative

Business Description

Founded in 1988 and headquartered in Vadodara, India, Rekvina Laboratories Limited produces and sells medicine products across the country. The company also works with other businesses to develop and manufacture pharmaceutical products on their behalf.

Key Fundamentals

EPS-0.57

RPS3.17

ROIC-33.23

ROA-78.66

EBITDA, mln-3.40

EV / EBITDA-184

EV / EBIT-184

Revenue, mln19.33

EV / Revenue32.33

Quote Details

Last 60.66

Change 2.56 (4.41%)

Open 60.80

Volume 3,601

Turnover 218,437

Average Volume 4,223.86

Financial Ratios

Pre-Tax Profit Margin-18

Current Ratio0.49

Price / Sales19.78

Financial Strength

Altman Z-Score10.84

Piotroski F-Score 5 / 9

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-2.32%	58 / 100
1 Month	16.79%	96 / 100
2 Months	86.13%	99 / 100
6 Months	49.19%	92 / 100